POET Technologies Inc. experienced a notable decline in its stock price on Tuesday, falling 7.7% to $13.46, even as the broader semiconductor sector enjoyed a significant rally. The drop came as investors digested the implications of a recently completed $400 million stock-and-warrant offering that has increased the company's share count and raised questions about dilution.
The Toronto-based company, which specializes in photonic integrated circuits for AI and hyperscale data centers, saw its shares trade between $13.14 and $15.44 after opening at $15.00. Trading volume surged to nearly 35 million shares, far exceeding typical levels. In contrast, the iShares Semiconductor ETF (SOXX) rose approximately 5.5%, and the Philadelphia Semiconductor Index hit an all-time high, buoyed by gains in major chip stocks like Micron and Marvell.
The $400 million financing, closed on May 18, involved the issuance of over 19 million common shares along with warrants exercisable for the same number of shares. The offering price was set at $21 per unit, meaning the current stock price is trading well below that level, indicating market skepticism about the near-term value of the capital raise. CEO Suresh Venkatesan stated that the funds would be used to expand manufacturing capacity by roughly tenfold to support higher-volume production by 2027.
While the additional capital provides POET with resources for factory expansion, engineering, and potential acquisitions, it also significantly dilutes existing shareholders. The stock's underperformance relative to the chip sector suggests that investors are questioning how quickly the new funds can be converted into tangible revenue growth.
The company's revenue base remains minimal. For the first quarter, POET reported total revenue of just $503,389, primarily from non-recurring engineering and product sales, compared to $166,760 a year earlier. The net loss widened to $12.3 million, or 8 cents per share, while operating cash flow was negative $8.8 million.
Adding to the challenges, in April, POET announced that Marvell Semiconductor, which had acquired Celestial AI, canceled all purchase orders previously received from Celestial, citing alleged breaches of confidentiality. POET stated it was pursuing deliveries for other customers, including a separate purchase order worth about $5 million. The loss of the Marvell/Celestial business represents a setback for the company's revenue trajectory.
On a more positive note, POET recently signed an agreement with Lumilens that includes an initial $50 million purchase order for electrical-optical interposer engines. The companies indicated that the relationship could scale to more than $500 million in cumulative purchases over five years, contingent on meeting development and manufacturing milestones. However, if the Lumilens ramp-up faces delays or qualification takes longer than anticipated, the $400 million financing could be viewed more as a financial cushion than a validation of demand.
Tax considerations also loom. POET has indicated it believes it will be classified as a passive foreign investment company (PFIC) for 2025, which could have adverse tax consequences for U.S. shareholders. CFO Thomas Mika noted that the company expects not to be a PFIC in 2026 and that the board intends to redomicile the company in the United States, subject to shareholder approval.
For now, the stock's performance hinges on execution versus dilution. The key test will be whether POET can convert the Lumilens order, its expanded capacity, and its stronger balance sheet into qualified products and shipments, moving beyond a compelling narrative in a hot segment of the chip market.
